Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
rTSST-1 Variant Candidate Vaccine
BIOLOGICAL
2 trials
Sponsors
Biomedizinische Forschungs gmbH
Conditions
Sepsis
Toxic Shock Syndrome
Toxic-Shock Syndrome
Vaccination; Sepsis
Phase 1
rTSST-1 Variant Vaccine Phase 1 First-in-man Trail
Completed
NCT02340338
Biomedizinische Forschungs gmbH
Toxic Shock Syndrome, Vaccination; Sepsis
Start: 2014-07-31
End: 2015-07-31
Updated: 2017-01-31
Amendment of rTSST-1 Variant Vaccine Phase 1 Clinical Trial
Completed
NCT02971670
Biomedizinische Forschungs gmbH
Sepsis, Toxic-Shock Syndrome
Start: 2015-10-31
End: 2016-05-31
Updated: 2017-06-09
Related Papers
High Titer Persistent Neutralizing Antibodies Induced by TSST-1 Variant Vaccine Against Toxic Shock Cytokine Storm
Toxins
2020-10-02
10 citations
Safety, tolerability, and immunogenicity of a recombinant toxic shock syndrome toxin (rTSST)-1 variant vaccine: a randomised, double-blind, adjuvant-controlled, dose escalation first-in-man trial.
2016-06-10
23 citations